Graham E. Quinn, MD, MSCE
Independent provider
About me
- Emeritus Professor CE of Ophthalmology
Education and training
- Medical School: Duke University School of Medicine
- Residency: Case Western Reserve University Hospital
- Residency: Scheie Eye Institute
- Fellowship: Children's Hospital of Philadelphia
My Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: On the medical staff, but does not have privileges to treat patients in the hospital.
- Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
Qualifications and experience
- Ophthalmology, 1979
- American Academy of Ophthalmology,
- American Academy of Pediatric Ophthalmology and Strabismus,
- American Academy of Pediatrics,
- Davison Society, Duke University,
- Delaware Valley Pediatric Ophthalmology Association,
- Pennsylvania Academy of Ophthalmology & Otolaryngology, Local
- Pennsylvania Medical Society,
- Philadelphia Medical Association,
- Philadelphia Pediatric Association,
Treatments and Conditions
My research
Lepore Domenico, Quinn Graham E, Molle Fernando, Baldascino Antonio, Orazi Lorenzo, Sammartino Maria, Purcaro Velia, Giannantonio Carmen, Papacci Patrizia, Romagnoli Costantino Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. , Ophthalmology, 121(11): 2014,2212-9
Quinn Graham E, Ying Gui-shuang, Daniel Ebenezer, Hildebrand P Lloyd, Ells Anna, Baumritter Agnieshka, Kemper Alex R, Schron Eleanor B, Wade Kelly Validity of a telemedicine system for the evaluation of acute-phase retinopathy of prematurity. , JAMA ophthalmology, 132(10): 2014,1178-84
Quinn GE on behalf of the e-ROP Cooperative Group Telemedicine approaches to evaluating acute-phase retinopathy of prematurity: study design. , Ophthalmic epidemiology, 21(4): 2014,256-67
Quinn Graham E, Fielder Alistair R Prevention of ROP blindness. , Clinics in perinatology, 40(2): 2013,xvii-xviii
Darlow Brian A, Ells Anna L, Gilbert Clare E, Gole Glen A, Quinn Graham E Are we there yet? Bevacizumab therapy for retinopathy of prematurity. , Archives of disease in childhood. Fetal and neonatal edition, 98(2): 2013,F170-4
Binenbaum Gil, Ying Gui-Shuang, Quinn Graham E, Huang Jiayan, Dreiseitl Stephan, Antigua Jules, Foroughi Negar, Abbasi Soraya The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. , Archives of ophthalmology, 130(12): 2012,1560-5
Quinn Graham E, Dobson Velma, Davitt Bradley V, Wallace David K, Hardy Robert J, Tung Betty, Lai Dejian, Good William V Progression of myopia and high myopia in the Early Treatment for Retinopathy of Prematurity study: findings at 4 to 6 years of age. , Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus, 17(2): 2013,124-8
Gordillo Luz, Villanueva Ana Maria, Quinn Graham E A practical method for reducing blindness due to retinopathy of prematurity in a developing country. , Journal of perinatal medicine, 40(5): 2012,577-82
Quinn G, Gilbert C Prevention of blindness in children throughout the world: how can we help? , Expert Rev Ophthalmol, 6(3): 2011,287-290
The International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. , Archives of ophthalmology, 123(7): 2005,991-9